HLB bioStep Co.,Ltd. (KOSDAQ:278650)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,420.00
0.00 (0.00%)
At close: Sep 3, 2026

HLB bioStep Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-18,428-18,962-8,564-164.04-1,00811,031
Depreciation & Amortization
4,8104,7314,7033,4764,1033,026
Loss (Gain) From Sale of Assets
997.79-16.35-135.089.47-209.1133.11
Asset Writedown & Restructuring Costs
4,9484,948--907.98-
Loss (Gain) From Sale of Investments
-1,552-1,714-182.73-3,418-534.22440.55
Loss (Gain) on Equity Investments
4,3104,460-1.68488.741,891-3,608
Stock-Based Compensation
1,1601,5411,445442.17444.01-
Provision & Write-off of Bad Debts
-262.71258.111,002-156.68712.06-409.25
Other Operating Activities
4,3683,859-2,0702,1754,8632,000
Change in Accounts Receivable
3,528-1,003-5,0351,441-1,277-1,362
Change in Inventory
-916.76-334.2847.63812.47-1,842-660.56
Change in Accounts Payable
1,0961,6231,299-476.321,815644.96
Change in Other Net Operating Assets
-3,0913,697-4,178561.78-3,386-2,673
Operating Cash Flow
966.243,086-11,6705,1926,4818,463
Operating Cash Flow Growth
----19.89%-23.42%-26.18%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3,483-1,973-8,924-4,002-4,894-19,598
Sale of Property, Plant & Equipment
8,586347.066,97138.18148.136.36
Cash Acquisitions
---2,730--9,707-107.5
Divestitures
----8,494-
Sale (Purchase) of Intangibles
-120.55-86.53-3-3.54-1,165-108.85
Investment in Securities
-5,367-3,9025,94357,393-78,115503.72
Other Investing Activities
-158.5-158.5-61.053,2363,650-163.07
Investing Cash Flow
-272.28-5,5021,46755,718-80,843-19,568

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--2,900-3,4002,462
Long-Term Debt Issued
-21,874100-81,1008,000
Total Debt Issued
1,65121,8743,000-84,50010,462
Short-Term Debt Repaid
--300-718.9--1,000-1,483
Long-Term Debt Repaid
--24,319-11,567-5,661-4,072-966.47
Total Debt Repaid
-1,002-24,619-12,286-5,661-5,072-2,449
Net Debt Issued (Repaid)
648.77-2,745-9,286-5,66179,4288,013
Issuance of Common Stock
-155.362,794183.18942.752,249
Repurchase of Common Stock
-39.63--5,910-1,422--
Dividends Paid
-----1,530-1,132
Other Financing Activities
0.491.24-25.11-854,22483.5
Financing Cash Flow
609.63-2,589-12,427-6,98583,0649,212

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-7.44-12.434.171.3614.019.91
Miscellaneous Cash Flow Adjustments
-0-----
Net Cash Flow
1,296-5,017-22,62553,9268,716-1,882

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2,5171,113-20,5941,1891,587-11,135
Free Cash Flow Growth
----25.03%--
Free Cash Flow Margin
-3.49%1.50%-35.40%2.25%1.84%-17.29%
Free Cash Flow Per Share
-152.2165.84-1226.9077.53113.33-795.47
Levered Free Cash Flow
-2,5971,907-11,123-586.771,307-16,022
Unlevered Free Cash Flow
-1,3153,189-10,5871,5833,961-15,907

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
398.15572.16498.23366.61401.2132.69
Cash Income Tax Paid
--72.94-107.2763.612,287891.74
Change in Working Capital
615.983,982-7,8662,339-4,689-4,051